Creo Medical Group (CREO)

Sector:

Health Care

Index:

FTSE AIM All-Share

13.25p
   
  • Change Today:
    -0.13p
  • 52 Week High: 34.00
  • 52 Week Low: 9.55
  • Currency: UK Pounds
  • Shares Issued: 412.47m
  • Volume: 275,484
  • Market Cap: £54.65m

CREO Overview

Creo Medical was founded in 2003 as MicroOncology Ltd by Professor Chris Hancock, initially to target the treatment of cancers through use of high frequency microwave energy and dynamic matching techniques.

1 Day Chart (19-06-2025)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -720.0% -54.8%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 13.7 2.3
Pr/Book 1.3  
Latest F'cast
Revenue n/a 336.9%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

CREO Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 9.43 (23.46) (12.54)p n/a n/a n/a n/a 0.0%
31-Dec-21 25.16 (30.34) (14.48)p n/a n/a n/a n/a 0.0%
31-Dec-22 27.20 (30.90) (14.48)p n/a n/a n/a n/a 0.0%
31-Dec-23 4.00 (26.40) (8.00)p n/a n/a n/a n/a 0.0%
31-Dec-24 4.00 (29.00) (8.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

CREO Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 17.47 (9.58) (2.03)p n/a n/a n/a n/a 0.0%
31-Dec-26 24.91 (13.32) (2.21)p n/a n/a n/a n/a 0.0%
31-Dec-27 17.87 (6.93) (1.28)p n/a n/a n/a n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Latest CREO Director Deals

Traded Action Notifier PriceAmountValue
30-May-25 Buy Kevin Crofton 15.75p 701,750 £110,525.62

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

CREO Market Data

Currency UK Pounds
Share Price 13.25p
Change Today -0.13p
% Change -0.93 %
52 Week High 34.00
52 Week Low 9.55
Volume 275,484
Shares Issued 412.47m
Market Cap £54.65m

CREO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
5.14% above the market average5.14% above the market average5.14% above the market average5.14% above the market average5.14% above the market average
12.5% below the sector average12.5% below the sector average12.5% below the sector average12.5% below the sector average12.5% below the sector average
Price Trend
82.13% below the market average82.13% below the market average82.13% below the market average82.13% below the market average82.13% below the market average
44.44% below the sector average44.44% below the sector average44.44% below the sector average44.44% below the sector average44.44% below the sector average
Income Not Available
Growth
47% below the market average47% below the market average47% below the market average47% below the market average47% below the market average
70.59% below the sector average70.59% below the sector average70.59% below the sector average70.59% below the sector average70.59% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CREO Dividends

No dividends found

Trades for 19-Jun-2025

Time Volume / Share Price
17:07 2,000 @ 13.25p
16:24 370 @ 13.50p
15:20 77 @ 13.07p
13:43 5,376 @ 13.37p
13:28 344 @ 13.05p

CREO Key Personnel

CEO Craig Jonathan Gulliford
CFO Richard John Rees

Top of Page